Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|January 27, 2018
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistanceIsabelle Malet, Francesca A Ambrosio, Frédéric Subra, et al.
Antiviral Therapy|October 26, 2011
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usageValentina Svicher, Claudia Alteri, Anna Artese, et al.
European Journal of Medicinal Chemistry|August 26, 2019
Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivativesRaffaella Catalano, Federica Moraca, Jussara Amato, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitorsSlim Fourati, Benoit Visseaux, Daniele Armenia, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated PatientsCarmen Gratteri, Francesca Alessandra Ambrosio, Antonio Lupia, et al.
Chemmedchem|May 23, 2014
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptaseRita Meleddu, Valeria Cannas, Simona Distinto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2010
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimensValentina Svicher, Claudia Alteri, Anna Artese, et al.
The Journal of Antimicrobial Chemotherapy|September 7, 2010
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitorsFrancesca Ceccherini-Silberstein, Isabelle Malet, Lavinia Fabeni, et al.
European Journal of Medicinal Chemistry|August 24, 2019
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activityFrancesca Esposito, Francesca Alessandra Ambrosio, Rita Maleddu, et al.
The Journal of Infectious Diseases|April 19, 2008
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failureValentina Svicher, Stefano Aquaro, Roberta D'Arrigo, et al.
Pageof 9